Insiders · Profile

Kawakami Mark

Chief Financial Officer at Arcadia Biosciences. Filing since 1 Aug 2024. CIK 0002030709

Company
Date
Role
Action
Shares
Amount
Of holding
3 Feb 2025
Chief Financial Officer
Bought
700
$1.74K
35.3%
1 Aug 2024
Chief Financial Officer
Bought
700
$1.44K
54.6%
2 decisions on file.